Abstract
Objective Technological advances made screen devices readily available, with adolescents spending an increasing amount of time on screens. Despite rising concerns, evidence on the relationship between screen-based activities and adolescent mental health remains inconsistent.
Method Using self-reports from the Norwegian Mother, Father, and Child Cohort Study and ICD-10 codes for mental illness from health registries, we estimated the odds of psychiatric diagnoses among adolescents across different levels of screen usage (n = 22,096). Additionally, we computed polygenic risk scores (PRSs) for schizophrenia (SCZ), bipolar disorder (BP), major depression, attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and alcohol use disorder (AUD) for adolescents without a history of mental illness and evaluated their association with time spent on screen-based activities.
Results We observed higher odds of psychiatric diagnoses among individuals with most time spent across all screen-based behaviors. However, the lowest social media usage was also associated with mental illness (OR 2.18, 95% CI: 1.80, 2.65), particularly with increased ASD occurrence. Minimum time spent on gaming was associated with lower odds of psychiatric diagnoses (OR 0.74, 95% CI: 0.65, 0.84). PRSADHD was positively associated with time spent on social media and gaming, while PRSASD was positively associated with gaming, but negatively – with social media usage. Additionally, social media usage was significantly associated with lower PRSSCZ and PRSBP, but higher PRSAUD.
Conclusion We show that screen time behaviors are associated with mental illness among adolescents, which may partly reflect a shared genetic basis.
Competing Interest Statement
Ole A. Andreassen is a consultant to HealthLytics and has received speakers honorarium from Lundbeck and Sunovion. No potential conflict of interest was reported by other authors.
Funding Statement
This work was supported by the Research Council of Norway (grants 324499, 326813, 324252, 271555/F21, 274611 MoBaGen, 324620 C-Me), The European Economic Area and Norway Grants (grants EEA-RO-NO-2018-0535, EEA-RO-NO-2018-0573), South-Eastern Norway Regional Health Authority (grant 2022072), European Unions Horizon 2020 Research and Innovation Programme Under the Marie Skłodowska-Curie Grant (grant 801133), European Unions Horizon 2020 Research and Innovation Programme (grant 964874 RealMent, grant 847776 CoMorMent).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The establishment of MoBa and initial data collection was based on a license from the Norwegian Data Protection Agency and approval from The Regional Committees for Medical and Health Research Ethics. The MoBa cohort is currently regulated by the Norwegian Health Registry Act. The current study was approved by The Regional Committees for Medical and Health Research Ethics (2016/1226/REK SØr-Øst C) in Norway.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All use of data and biological material from MoBa is subject to Norwegian law. Information about the requirements needed to gain access to data from MoBa is provided here: https://www.fhi.no/en/ch/studies/moba/for-forskere-artikler/research-and-data-access/
